Adaptimmune Therapeutics PLC Quarterly Operating Margin in % from Q4 2017 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q4 2024.
  • Adaptimmune Therapeutics PLC Operating Margin for the quarter ending December 31, 2024 was -38.6 %, a 83.3% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2024 was -38.6 %, a 83.3% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2023 was -232 %, a 61.6% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2022 was -604 %, a 77.1% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -38.6 +193 +83.3% Oct 1, 2024 Dec 31, 2024
Q3 2024 -25.8 +139 +84.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -54.5 +106 +66% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.04K -881 -558% Jan 1, 2024 Mar 31, 2024
Q4 2023 -232 +372 +61.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -165 +859 +83.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -160 +1.36K +89.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -158 +1.72K +91.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -604 +2.03K +77.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.02K +1.49K +59.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.52K +896 +37% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.88K +2.02K +51.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.64K +732 +21.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.52K +1.45K +36.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.42K +3.44K +58.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -3.9K +3.31K +45.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.37K +9.09K +72.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.97K +3.57K +47.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -5.86K -5.64K -2542% Apr 1, 2020 Jun 30, 2020
Q1 2020 -7.21K -7.04K -4131% Jan 1, 2020 Mar 31, 2020
Q4 2019 -12.5K -12.3K -8900% Oct 1, 2019 Dec 31, 2019
Q3 2019 -7.54K -7.41K -5748% Jul 1, 2019 Sep 30, 2019
Q2 2019 -222 -32.1 -17% Apr 1, 2019 Jun 30, 2019
Q1 2019 -170 +31.6 +15.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -138 +74.8 +35.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -129 Jul 1, 2018 Sep 30, 2018
Q2 2018 -190 Apr 1, 2018 Jun 30, 2018
Q1 2018 -202 Jan 1, 2018 Mar 31, 2018
Q4 2017 -213 Oct 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.